Home

Supporting BCI & Neurotechnology Innovation on the Path to Commercialization

Helping breakthrough neurotechnology and MedTech companies navigate complex regulatory pathways, build scalable quality systems, and accelerate global market access.

Regulatory, Quality & Clinical Strategy for BCI & Neurotechnology

GlobalPath provides regulatory, quality, and clinical strategy advisory services to companies working in some of the most complex and rapidly evolving areas of medical technology, including **brain-computer interfaces (BCIs), neurotechnology, neurosurgery, cortical interfaces, and implantable neurological devices.**

Trusted by MedTech Leaders Worldwide

GlobalPath works with organizations at every stage of growth, from early-stage innovators to multinational companies, providing regulatory, quality, and market access expertise across the product lifecycle.

How We Help MedTech Innovators Succeed

GlobalPath provides strategic and hands-on support across regulatory, quality, clinical, and commercialization challenges.

Why GlobalPath

GlobalPath brings **more than 25 years of MedTech regulatory and quality leadership experience spanning 30+ global jurisdictions**, working with medical technology companies across established and emerging fields, including neurotechnology and brain-computer interfaces (BCIs). Our core strengths are in **regulatory affairs, quality management, and clinical strategy**, with a strong commitment to **patient safety and medical device safety and effectiveness**. We work alongside MedTech leadership teams to navigate complex regulatory, quality, and clinical challenges, engage with regulatory authorities, and develop practical strategies that support regulatory compliance, clinical evidence generation, and the advancement of innovative medical technologies toward regulatory approval, market access, and commercialization.

Global Expertise. Specialized Insight.

BCI & Neurotechnology | Regulatory | Quality | Clinical Strategy | Global Market Access